Skip to main content

Peer Review reports

From: Relationships between developmental strategies for additional indications and price revisions for anticancer drugs in Japan

Original Submission
14 Aug 2021 Submitted Original manuscript
30 Sep 2021 Reviewed Reviewer Report - Xiaodong Guan
6 Oct 2021 Reviewed Reviewer Report
15 Oct 2021 Author responded Author comments - Hideki Maeda
Resubmission - Version 2
15 Oct 2021 Submitted Manuscript version 2
4 Nov 2021 Reviewed Reviewer Report
5 Nov 2021 Reviewed Reviewer Report - Xiaodong Guan
21 Nov 2021 Author responded Author comments - Hideki Maeda
Resubmission - Version 3
21 Nov 2021 Submitted Manuscript version 3
Publishing
30 Nov 2021 Editorially accepted
11 Dec 2021 Article published 10.1186/s12913-021-07360-w

You can find further information about peer review here.

Back to article page